Kimberly‑Clark said on Nov. 3, 2025 that it is planning to acquire Kenvue, the former Johnson & Johnson unit and maker of major United States brands like Band-Aid and Tylenol, for approximately $48.7 ...

As a part of its CPHI Frankfurt 2025 coverage, Pharmaceutical Technology ® interviewed Sriman Banerjee, PhD, executive ...

As Thermo Fisher’s Jennifer Cannon explains in this first part of a two-part interview, the collaboration is intended to help ...

CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, ...

In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will ...

The Critical Medicines Act (CMA) addresses supply chain vulnerabilities by redefining procurement criteria, emphasizing quality, security, and environmental standards. European manufacturers gain ...

In the first part of this interview, Romanski tells PharmTech Group that while the field of oral dosage forms has not grown ...

In this part 2 of a 2-part interview regarding the presentation “Beyond Traditional Markets: The Strategic Importance of ...

When it comes to sustainability, Reed points to plant-based excipients, eco-efficient manufacturing, and bio-based circular ...

AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...

Nigel Langley of gChem stresses excipient innovation, safer solvents, and supply chain resilience for pharma’s future in part ...

Maggie Saykali, Cefic, explains that Western pharma vulnerability stems from market loss to Asia, caused largely by ...